Free Trial
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free GANX Stock Alerts

Gain Therapeutics (GANX) Short Interest Ratio & Short Volume

Gain Therapeutics logo
$1.78 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$1.78 -0.01 (-0.28%)
As of 05/22/2026 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Gain Therapeutics Short Interest Overview

As of April 30, 2026, Gain Therapeutics (GANX) had a short interest of 3.44 million shares sold short, representing 8.42% of the public float. This marks a 3.34% increase in short interest since the prior report. The short interest ratio (days to cover) is 6.3, meaning it would take 6.3 days of the average trading volume of 531,560 shares to cover all short positions.

Current Short Interest
3,442,408 shares
Previous Short Interest
3,331,182 shares
Change Vs. Previous Month
3.34%
Dollar Volume Sold Short
$6.51 million
Short Interest Ratio
6.3 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
42,650,000 shares
Short Percent of Float
8.42%
Today's Trading Volume
412,494 shares
Average Trading Volume
531,560 shares
Today's Volume Vs. Average
78%
Short Selling Gain Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Gain Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GANX Short Interest Over Time

GANX Days to Cover Over Time

GANX Percentage of Float Shorted Over Time

Gain Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20263,442,408 shares $6.51 million +3.3%8.4%6.33 $1.89
4/15/20263,331,182 shares $7.13 million +1.5%8.5%5.79 $2.14
3/31/20263,282,560 shares $6.37 million +14.2%8.4%4.03 $1.94
3/13/20262,873,797 shares $6.98 million -0.3%8.0%3.59 $2.43
2/27/20262,883,705 shares $7.53 million -5.1%8.1%4.08 $2.61
2/13/20263,039,619 shares $5.50 million +2.1%8.5%5.92 $1.81
1/30/20262,976,352 shares $5.36 million +19.9%8.3%3.74 $1.80
1/15/20262,482,134 shares $4.67 million -6.9%7.0%1.83 $1.88
12/31/20252,666,410 shares $8.59 million +28.6%7.5%0.99 $3.22
12/15/20252,073,310 shares $8.19 million +64.5%5.8%1.5 $3.95
11/28/20251,260,732 shares $4.51 million -29.2%3.5%1.28 $3.58
11/14/20251,781,339 shares $5.04 million +95.6%5.3%1.16 $2.83
10/31/2025910,705 shares $1.78 million -28.3%2.7%1.37 $1.96
10/15/20251,270,000 shares $2.37 million +200.7%3.7%2 $1.87
9/30/2025422,300 shares $747.47 thousand +12.0%1.2%0.8 $1.77
9/15/2025377,100 shares $618.44 thousand +61.6%1.1%0.9 $1.64
8/31/2025233,300 shares $464.27 thousand +10.6%0.7%0.6 $1.99
8/15/2025210,900 shares $364.86 thousand -13.2%0.6%0.7 $1.73
7/31/2025243,000 shares $354.78 thousand +22.2%0.7%0.9 $1.46
7/15/2025198,800 shares $337.96 thousand -21.1%0.6%0.7 $1.70
6/30/2025252,100 shares $453.78 thousand +8.5%0.9%0.9 $1.80
6/15/2025232,300 shares $401.88 thousand -20.4%0.8%0.8 $1.73
5/31/2025291,800 shares $517.95 thousand +0.6%1.0%1.1 $1.78
5/15/2025290,200 shares $525.26 thousand -1.9%1.0%1 $1.81
4/30/2025295,800 shares $606.39 thousand +5.8%1.1%1.1 $2.05
4/15/2025279,700 shares $503.46 thousand -7.6%1.0%1.1 $1.80
3/31/2025302,700 shares $578.16 thousand -7.4%1.2%1.3 $1.91
3/15/2025326,700 shares $689.34 thousand -6.3%1.3%1.3 $2.11
2/28/2025348,800 shares $742.94 thousand -24.5%1.4%1.5 $2.13
2/15/2025462,200 shares $1.26 million +26.6%1.8%2 $2.73
1/31/2025365,100 shares $777.66 thousand -2.5%1.5%1.6 $2.13
1/15/2025374,600 shares $801.64 thousand +11.8%1.5%1.5 $2.14
12/31/2024335,200 shares $724.03 thousand +0.2%1.3%1.1 $2.16
12/15/2024334,700 shares $545.56 thousand -42.4%1.3%1.1 $1.63
11/30/2024580,600 shares $1.08 million -19.2%2.3%1.8 $1.86
11/15/2024718,700 shares $1.33 million +9.2%2.9%1.9 $1.85
10/31/2024658,300 shares $1.65 million +15.1%2.7%1.6 $2.50
10/15/2024572,000 shares $1.37 million -12.6%2.4%1.5 $2.40
9/30/2024654,300 shares $1.16 million +12.8%2.7%1.8 $1.78
9/15/2024580,300 shares $850.14 thousand +4.5%2.4%1.7 $1.47
June 12: $100 Turns Into $100,000? (Ad)

The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast. Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears.tc pixel

Click here to see how to get ahead of the SpaceX IPO
8/31/2024555,400 shares $605.39 thousand +195.1%2.3%1.3 $1.09
8/15/2024188,200 shares $231.49 thousand +2.0%0.8%0.6 $1.23
7/31/2024184,600 shares $199.37 thousand +120.3%0.8%0.6 $1.08
7/15/202483,800 shares $104.75 thousand -56.6%0.5%0.3 $1.25
6/30/2024193,000 shares $247.04 thousand -61.4%1.2%0.8 $1.28
6/15/2024500,300 shares $620.37 thousand +521.5%3.0%2.3 $1.24
5/31/202480,500 shares $205.28 thousand -20.1%0.5%0.7 $2.55
5/15/2024100,700 shares $263.83 thousand -34.7%0.6%0.9 $2.62
4/30/2024154,200 shares $451.81 thousand +3.1%1.0%1 $2.93
4/15/2024149,600 shares $462.26 thousand +8.3%1.1%0.9 $3.09
3/31/2024138,100 shares $520.64 thousand -11.9%1.0%0.9 $3.77
3/15/2024156,700 shares $672.24 thousand +16.4%0.9%0.9 $4.29
2/29/2024134,600 shares $604.35 thousand -2.2%0.8%0.8 $4.49
2/15/2024137,600 shares $660.48 thousand +13.4%0.8%0.9 $4.80
1/31/2024121,300 shares $469.43 thousand +17.2%0.7%0.8 $3.87
1/15/2024103,500 shares $361.22 thousand +66.1%0.6%1.2 $3.49
12/31/202362,300 shares $203.41 thousand -42.0%0.4%0.7 $3.27
12/15/2023107,400 shares $268.50 thousand -25.0%0.6%1.6 $2.50
11/30/2023143,200 shares $306.45 thousand -18.9%1.2%2.4 $2.14
11/15/2023176,500 shares $511.85 thousand -3.2%1.7%3.8 $2.90
10/31/2023182,400 shares $521.66 thousand -9.5%1.8%4.9 $2.86
10/15/2023201,600 shares $665.28 thousand +6.4%2.0%4.8 $3.30
9/30/2023189,500 shares $621.56 thousand +5.2%1.9%4.5 $3.28
9/15/2023180,100 shares $666.37 thousand +14.1%1.8%5.5 $3.70
8/31/2023157,900 shares $522.65 thousand -6.4%1.6%4.5 $3.31
8/15/2023168,600 shares $606.96 thousand +61.5%1.7%4.3 $3.60
7/31/2023104,400 shares $414.47 thousand +66.0%1.1%2.3 $3.97
7/15/202362,900 shares $279.28 thousand -6.5%0.7%0.9 $4.44
6/30/202367,300 shares $301.50 thousand +21.7%0.7%1 $4.48
6/15/202355,300 shares $269.31 thousand +24.8%0.6%0.8 $4.87
5/31/202344,300 shares $204.22 thousand -19.6%0.5%0.5 $4.61
5/15/202355,100 shares $279.91 thousand -7.9%0.6%0.7 $5.08
4/30/202359,800 shares $300.79 thousand -7.1%0.7%0.8 $5.03
4/15/202364,400 shares $308.48 thousand +7.3%0.7%0.9 $4.79
3/31/202360,000 shares $289.20 thousand +20.2%0.7%1.1 $4.82
3/15/202349,900 shares $220.56 thousand +64.1%0.6%0.9 $4.42
2/28/202330,400 shares $126.46 thousand +35.7%0.3%0.7 $4.16
2/15/202322,400 shares $87.36 thousand -16.7%0.3%0.5 $3.90
1/31/202326,900 shares $106.26 thousand +45.4%0.3%0.7 $3.95
1/15/202318,500 shares $71.78 thousand -70.5%0.2%0.5 $3.88
12/30/202262,700 shares $196.25 thousand -10.7%0.6%1.9 $3.13
12/15/202270,200 shares $210.60 thousand +146.3%0.7%2.3 $3.00
11/30/202228,500 shares $86.64 thousand -25.4%0.3%1 $3.04
11/15/202238,200 shares $119.18 thousand -21.1%0.4%1.2 $3.12
10/31/202248,400 shares $161.66 thousand +6.6%0.5%1.4 $3.34
10/15/202245,400 shares $143.01 thousand -30.3%0.5%1.2 $3.15
9/30/202265,100 shares $212.23 thousand +50.0%0.8%1.5 $3.26
9/15/202243,400 shares $169.26 thousand +80.8%0.6%1 $3.90
8/31/202224,000 shares $82.80 thousand -35.0%0.3%0.5 $3.45
8/15/202236,900 shares $153.14 thousand -27.8%0.5%0.7 $4.15
Musk's shopping list: batteries ✓ solar ✓ data ✓ power ___ (Ad)

Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity for $2.6 billion and Twitter for $44 billion. Now one small company makes the equipment his Colossus supercomputer - a million GPUs consuming nearly $1 billion a month in power - cannot run without. Analyst Dylan Jovine has identified the name and ticker. For investors who own shares before a potential move, the math could be significant.tc pixel

See the stock Musk's acquisition pattern points to next
7/31/202251,100 shares $203.38 thousand +29.4%0.7%0.7 $3.98
7/15/202239,500 shares $158.40 thousand -17.9%0.5%0.5 $4.01
6/30/202248,100 shares $173.16 thousand -30.9%0.6%0.3 $3.60
6/15/202269,600 shares $224.81 thousand +18.2%0.9%0.4 $3.23
5/31/202258,900 shares $175.52 thousand -24.6%0.8%0.4 $2.98
5/15/202278,100 shares $208.53 thousand +125.1%1.0%0.5 $2.67
4/30/202234,700 shares $118.67 thousand -4.9%0.5%0.2 $3.42
4/15/202236,500 shares $140.16 thousand No Change0.5%0.3 $3.84
3/31/202236,500 shares $149.29 thousand +18.5%0.5%0.6 $4.09
3/15/202230,800 shares $103.18 thousand -17.9%0.4%0.6 $3.35
2/28/202237,500 shares $138.38 thousand -42.0%0.5%0.7 $3.69
2/15/202264,700 shares $270.45 thousand +100.3%0.8%1.1 $4.18
1/31/202232,300 shares $129.20 thousand -8.0%0.4%0.4 $4.00
1/15/202235,100 shares $164.27 thousand +30.0%0.5%0.4 $4.68
12/31/202127,000 shares $146.61 thousand -25.4%0.4%0.4 $5.43
12/15/202136,200 shares $204.53 thousand -14.6%0.5%0.5 $5.65
11/30/202142,400 shares $306.98 thousand +74.5%0.6%0.5 $7.24
11/15/202124,300 shares $208.01 thousand +35.0%0.3%0.1 $8.56
10/29/202118,000 shares $125.28 thousand -23.7%0.2%0.1 $6.96
10/15/202123,600 shares $163.78 thousand -5.2%0.3%0.2 $6.94
9/30/202124,900 shares $185.51 thousand -63.5%0.3%0.2 $7.45
9/15/202168,200 shares $543.55 thousand +170.6%0.9%0.5 $7.97
8/31/202125,200 shares $196.56 thousand -42.1%0.3%0.2 $7.80
8/13/202143,500 shares $348 thousand No Change0.6%1.6 $8.00

GANX Short Interest - Frequently Asked Questions

Short interest is the volume of Gain Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 3,442,408 shares of GANX short. 8.42% of Gain Therapeutics' shares are currently sold short. Learn More on Gain Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GANX shares currently have a short interest ratio of 6.3. Learn More on Gain Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.42% of Gain Therapeutics' floating shares are currently sold short.

Gain Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 3,442,408 shares, an increase of 3.3% from the previous total of 3,331,182 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

8.42% of Gain Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Gain Therapeutics: Eledon Pharmaceuticals, Inc. (11.16%), Nuvectis Pharma, Inc. (7.94%), Prelude Therapeutics Incorporated (4.86%), Akebia Therapeutics, Inc. (10.76%), Compugen Ltd. (1.66%), ALX Oncology Holdings Inc. (2.08%), Anavex Life Sciences Corp. (23.05%), Protara Therapeutics, Inc. (11.79%), Zentalis Pharmaceuticals, Inc. (7.86%), Editas Medicine, Inc. (10.55%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling GANX is an investing strategy that aims to generate trading profit from Gain Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Gain Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GANX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GANX, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like GANX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:GANX) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Gold surged 600 dollars last time this indicator peaked
The Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...
Porter & Company | Sponsoredtc pixel
Opportunity Forming in a U.S. Supply-Chain Weak Spot?
America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...
i2i Marketing Group, LLC | Sponsoredtc pixel